Profile

The funds advised by Orlando Management AG invest in companies, spin-outs, spin-offs, subsidiaries and divisions with a turnover of up to EUR 500 m. For transaction volumes exceeding EUR 200 m, co-investors are brought in. Geographically, our focus is on Germany, Austria, Switzerland and the Nordics. Add-on acquisitions are pursued worldwide. We do not restrict ourselves to particular industries. Start-ups, companies involved in the fundamental development of high-tech products and biotechnology firms are excluded.

Orlando Management AG looks for market-ready medium-sized companies, group subsidiaries or divisions in spin-off situations. Companies and divisions with a turnover of up to EUR 500 m and an EBIT ranging from negative to high double-digit positive percentage are in the focus. The market for the company’s core business should be stable and its market position defensible. Orlando does not restrict itself to particular industries. Complexity is not a problem. Bank financing can be dissolved if needed; if transaction volumes exceed EUR 200 m, co-investors are welcomed. Geographically, our focus is on Germany, Austria and Switzerland, but add-on acquisitions are sought throughout the world. The funds have also acquired special situations from other Private Equity funds’ portfolios.

We specialize in the reorientation of companies, management buy-outs, management buy-ins, turnaround consulting, succession issues, companies with liquidity difficulties, financing of add-ons to access new markets, spin-outs requiring capital and management capacity, companies with poor earnings positions, and even insolvent companies. The funds advised by us acquire majority shareholdings.

• Mature medium-sized companies
• Corporate subsidiaries and business units
• Sales up to EUR 500 m
• EBIT-Returns: negative up to high double-digit positive

• Stable core market
• Defendable market position

• No industry constraints

• Complexity is no handicap
• Buying out bank loans
• Transaction volume up to EUR 200 m. higher amounts with co-investors

• DACH und Nordics
• „Add-on“ acquisitions worldwide

• Start ups, launch of unproven high-tech products, biotechnology